These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 14551884

  • 1. Effects of total body irradiation and cyclosporin a on the lethality of toxic shock syndrome toxin-1 in a rabbit model of toxic shock syndrome.
    Dinges MM, Gregerson DS, Tripp TJ, McCormick JK, Schlievert PM.
    J Infect Dis; 2003 Oct 15; 188(8):1142-5. PubMed ID: 14551884
    [Abstract] [Full Text] [Related]

  • 2. Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1.
    Miethke T, Duschek K, Wahl C, Heeg K, Wagner H.
    Eur J Immunol; 1993 Jul 15; 23(7):1494-500. PubMed ID: 8325325
    [Abstract] [Full Text] [Related]

  • 3. Co-production of staphylococcal enterotoxin A with toxic shock syndrome toxin-1 (TSST-1) enhances TSST-1 mediated mortality in a D-galactosamine sensitized mouse model of lethal shock.
    De Boer ML, Kum WW, Pang LT, Chow AW.
    Microb Pathog; 1999 Aug 15; 27(2):61-70. PubMed ID: 10458917
    [Abstract] [Full Text] [Related]

  • 4. Staphylococcus aureus isogenic mutant, deficient in toxic shock syndrome toxin-1 but not staphylococcal enterotoxin A production, exhibits attenuated virulence in a tampon-associated vaginal infection model of toxic shock syndrome.
    De Boer ML, Kum WW, Chow AW.
    Can J Microbiol; 1999 Mar 15; 45(3):250-6. PubMed ID: 10408098
    [Abstract] [Full Text] [Related]

  • 5. A severe case of neonatal toxic shock syndrome-like exanthematous disease with superantigen-induced high T cell response.
    Miki M, Uchiyama T, Kato H, Nishida H, Takahashi N.
    Pediatr Infect Dis J; 2006 Oct 15; 25(10):950-2. PubMed ID: 17006297
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Toxic shock syndrome toxin-1-induced death is prevented by CTLA4Ig.
    Saha B, Jaklic B, Harlan DM, Gray GS, June CH, Abe R.
    J Immunol; 1996 Nov 01; 157(9):3869-75. PubMed ID: 8892617
    [Abstract] [Full Text] [Related]

  • 8. Defining a novel domain of staphylococcal toxic shock syndrome toxin-1 critical for major histocompatibility complex class II binding, superantigenic activity, and lethality.
    Kum WW, Laupland KB, Chow AW.
    Can J Microbiol; 2000 Feb 01; 46(2):171-9. PubMed ID: 10721486
    [Abstract] [Full Text] [Related]

  • 9. Immunobiologic and biochemical properties of mutants of toxic shock syndrome toxin-1.
    Murray DL, Prasad GS, Earhart CA, Leonard BA, Kreiswirth BN, Novick RP, Ohlendorf DH, Schlievert PM.
    J Immunol; 1994 Jan 01; 152(1):87-95. PubMed ID: 8254210
    [Abstract] [Full Text] [Related]

  • 10. Defense against biologic warfare with superantigen toxins.
    Kaempfer R, Arad G, Levy R, Hillman D.
    Isr Med Assoc J; 2002 Jul 01; 4(7):520-3. PubMed ID: 12120463
    [Abstract] [Full Text] [Related]

  • 11. Vaccination with nontoxic mutant toxic shock syndrome toxin 1 protects against Staphylococcus aureus infection.
    Hu DL, Omoe K, Sasaki S, Sashinami H, Sakuraba H, Yokomizo Y, Shinagawa K, Nakane A.
    J Infect Dis; 2003 Sep 01; 188(5):743-52. PubMed ID: 12934191
    [Abstract] [Full Text] [Related]

  • 12. Toxic shock syndrome--the role of the toxin.
    Bergdoll MS, Reiser RF, Crass BA, Robbins RN, Thompson NE.
    Postgrad Med J; 1985 Sep 01; 61 Suppl 1():35-8. PubMed ID: 3932991
    [Abstract] [Full Text] [Related]

  • 13. Animal studies of toxic shock syndrome.
    Quimby F, Nguyen HT.
    Crit Rev Microbiol; 1985 Sep 01; 12(1):1-44. PubMed ID: 3160540
    [Abstract] [Full Text] [Related]

  • 14. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.
    Arad G, Levy R, Hillman D, Kaempfer R.
    Nat Med; 2000 Apr 01; 6(4):414-21. PubMed ID: 10742148
    [Abstract] [Full Text] [Related]

  • 15. Toxic shock syndrome: characterization of human immune responses to TSST-1 and evidence for sensitivity thresholds.
    Kimber I, Nookala S, Davis CC, Gerberick GF, Tucker H, Foertsch LM, Dearman RJ, Parsonnet J, Goering RV, Modern P, Donnellen M, Morel J, Kotb M.
    Toxicol Sci; 2013 Jul 01; 134(1):49-63. PubMed ID: 23640863
    [Abstract] [Full Text] [Related]

  • 16. Analysis of superantigenic toxin Vbeta T-cell signatures produced during cases of staphylococcal toxic shock syndrome and septic shock.
    Ferry T, Thomas D, Perpoint T, Lina G, Monneret G, Mohammedi I, Chidiac C, Peyramond D, Vandenesch F, Etienne J.
    Clin Microbiol Infect; 2008 Jun 01; 14(6):546-54. PubMed ID: 18373692
    [Abstract] [Full Text] [Related]

  • 17. T-cell response to superantigen restimulation during menstrual toxic shock syndrome.
    Rasigade JP, Thomas D, Perpoint T, Peyramond D, Chidiac C, Etienne J, Vandenesch F, Lina G, Ferry T.
    FEMS Immunol Med Microbiol; 2011 Aug 01; 62(3):368-71. PubMed ID: 21492259
    [Abstract] [Full Text] [Related]

  • 18. Production of human and murine interleukin-2 by toxic shock syndrome toxin-1.
    Micusan VV, Mercier G, Bhatti AR, Reiser RF, Bergdoll MS, Oth D.
    Immunology; 1986 Jun 01; 58(2):203-8. PubMed ID: 3486824
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.